Publications
Search
Journal of Clinical Pathways
05/08/2024
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
EP Lab Digest
05/08/2024
AUSTIN, Texas—On April 18-19, 2024, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center hosted its seventh international symposium on complex arrhythmias, EPLive 2024. This year’s event included 1,000 registered attendees from all over the globe, including Argentina, Italy and Japan, with more than 250 people attending in person.
Oncology
05/08/2024
According to a retrospective study, rituximab-bendamustine followed by rituximab maintenance among patients with previously untreated advanced FL resulted in longer progression-free survival than rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone followed by rituximab maintenance.
Oncology
05/08/2024
At Great Debates and Updates in Women’s Oncology, Seth Wander, MD, PhD, discussed whether novel endocrine agents add anything different from SERDs to treatments for patients with hormone receptor-positive metastatic v breast cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
The guideline reiterates the importance of collaborative decision-making with patients who have HCM and provides updated recommendations for the most effective treatment pathways for adult and pediatric patients.
EMSWorld
05/08/2024
Find out how two first responders raced to save a driver who became unresponsive behind the wheel.
EMSWorld
05/08/2024
Known as the Medical Priority Dispatch System (MPDS), this new system went live at the Ottawa Central Ambulance Communications Center on April 10, 2024.
Oncology
05/08/2024
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Oladapo Yeku, MD, PhD, FACP participated in a debate arguing for the incorporation of immunotherapy for patients with cervical cancer in the recurrent or metastatic setting.
Oncology
05/08/2024
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Ying Liu, MD, MPH, makes an argument for platinum-based chemotherapy as the optimal treatment for patients with platinum-sensitive recurrent ovarian cancer.
Cath Lab Digest, Vascular Disease Management, Journal of Invasive Cardiology, CardioVascular
05/08/2024
The prospective, single-arm, multicenter study will examine the efficacy and safety of the Spur Stent for the treatment of vascular lesions in the infrapopliteal arteries below the knee. A novel device intended for use in patients with critical limb-threatening ischemia (CLTI), this Retrievable Scaffold Therapy (RST) features a retrievable stent with radially self-expanding spikes that treat the diseased vessel wall without leaving anything behind.
The Dermatologist
05/08/2024
The session aimed to delve into recent advancements in dermatology research, guided by Dr Gelfand, a leading figure in clinical dermatology research.
Oncology
05/08/2024
At Great Debates and Updates in Women’s Oncology, Denise Yardley, MD, discusses whether age 50 is relevant for treatment decisions for patients with early HR-positive breast cancer.
The Dermatologist
05/08/2024
Researchers aimed to identify prognostic and predictive biomarkers for adjuvant anti-PD-1 therapy in patients with macroscopic stage III melanoma.
Veterans Health Today
05/08/2024
Researchers explore how military medicine has played a crucial role in advancing civilian health care and public health, and the potential benefits of increased collaboration between military and civilian health systems in an essay published in JAMA Open Network.
APP Institute Oncology
05/08/2024
Sarah Smith, BD, CNMT, discusses findings from the phase 3 MARIPOSA study exploring post-progression and safety outcomes with first-line amivantamab plus lazertinib vs osimertinib for advanced NSCLC and offers guidance for best management practices.
Annals of Long-Term Care
05/08/2024
Deep brain stimulation of the subthalamic nucleus (STN-DBS) results in a stable quality of life (QOL) over 5 years in patients with advanced Parkinson disease, according to a study published in JAMA Network Open.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
Dr. W. Frank Peacock discussed a recently completed biomarker study that enrolled 840 individuals across 10 hospital locations in the United States. The study involved participants wearing RCE’s Infrasensor™ wearable device for three minutes during which blood samples were collected for biochemical analysis.
Oncology
05/08/2024
At Great Debates and Updates in Women’s Oncology, Neil Iyengar, MD, discusses the lack of data to support the sequential use of antibody drug conjugates for patients with metastatic breast cancer.
Cath Lab Digest, Journal of Invasive Cardiology, CardioVascular
05/08/2024
Researchers at the University of Houston College of Pharmacy have discovered that when there's a higher amount of a protein called AKAP12 inside the heart, it speeds up the work of an enzyme called PDE8A and can accelerate cardiac dysfunction.
Oncology
05/08/2024
At the 2024 Great Debates and Updates in Women’s Oncology meeting, Bradley Monk, MD, FACOG, argues for the first-line use of immune checkpoint inhibitors plus chemotherapy and radiation therapy for patients with cervical cancer.